Spineart is pleased to announce the FDA approval for the ROMEO®2 PAD Posterior Axial Device, a posterior non pedicle supplemental fixation device intended for use as an adjunct to fusion in the lumbar spine.
The ROMEO®2 PAD Posterior Axial Device consists of two plates and a central core. It features 30° of plate poliaxiality, to adapt to the anatomy of the patient. The easy one-step locking mechanism allows the surgeon to compress, fix and lock the device at the same time. The instrument set follows the Spineart compact philosophy, featuring one box of intuitive instruments.
All Spineart implants are sterile packed and bar-coded for increased safety, procedure compliance and cost-efficiency.
About Spineart:
Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients.
Spineart is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment.
Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital.
For more information please contact us at contact@spineart.com or visit spineart.com.